All the patients in the phase 2 study received cyclophosphamide, tacrolimus and mycophenolate mofetil for graft-vs-host ...

PTCy plus cyclosporine proved more effective than standard GVHD prophylaxis in patients undergoing matched sibling PBSCT in a phase 3 trial.

Cristiano Ronaldo, the soccer player who is called the end of self-management, 2020 Mr. Olympia Big Ramy, and Hiddink, the ...

After six inspiring weeks at Samuel Marsden Collegiate School, award-winning artist Connah Podmore concludes her time as the ...

Physicians from Bochum have used a cancer treatment method to treat severe autoimmune diseases.

Smith, 7, diagnosed with a rare blood disorder, receives a life-saving stem cell transplant from his father, Matt, offering ...

Haematology's profound transformation offers new hope through advanced diagnostics, personalized medicine, and the noble act ...

Data from the POLARGO trial potentially establishes a new standard of care for patients with R/R DLBCL ineligible for ...

intmed1.med.kyushu-u.ac.jp Objectives: To carry out a phase I-II trial to elucidate the feasibility and efficacy of high dose cyclophosphamide (CY) supported by autologous peripheral blood stem cell ...

Rates of grade III/IV acute GVHD at 3 months were 3% with cyclophosphamide-cyclosporin prophylaxis and 10% with standard prophylaxis, reported David Curtis, MBBS, PhD, of Alfred H ...

Join Drs Tania Jain and Rachel Salit as they explore evolving definitions of remission, relapse monitoring, and ...